$3.07 Billion is the total value of HealthCor Management, L.P.'s 37 reported holdings in Q4 2017. The portfolio turnover from Q3 2017 to Q4 2017 was 47.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Buy | MERCK & CO INC | $219,453,000 | +395.8% | 3,900,000 | +464.2% | 7.14% | +381.6% |
| BIVV | Sell | BIOVERATIV INC | $202,200,000 | -14.6% | 3,750,000 | -9.6% | 6.58% | -17.1% |
| ZBH | Sell | ZIMMER BIOMET HLDGS INC | $184,022,000 | -7.2% | 1,525,000 | -9.9% | 5.99% | -9.8% |
| CELG | Buy | CELGENE CORP | $180,021,000 | +127.3% | 1,725,000 | +217.6% | 5.86% | +120.8% |
| LH | Sell | LABORATORY CORP AMER HLDGS | $175,461,000 | -26.1% | 1,100,000 | -30.0% | 5.71% | -28.2% |
| MDT | Buy | MEDTRONIC PLC | $157,463,000 | +2962.9% | 1,950,000 | +2850.1% | 5.12% | +2879.7% |
| AGN | Buy | ALLERGAN PLC | $134,954,000 | +14.9% | 825,000 | +43.9% | 4.39% | +11.6% |
| INCY | Buy | INCYTE CORP | $127,859,000 | +83.0% | 1,350,000 | +125.5% | 4.16% | +77.7% |
| PCRX | Buy | PACIRA PHARMACEUTICALS INC | $127,820,000 | +32.0% | 2,800,000 | +8.6% | 4.16% | +28.2% |
| REGN | New | REGENERON PHARMACEUTICALS | $122,187,000 | – | 325,000 | +100.0% | 3.98% | – |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $118,325,000 | -7.5% | 1,525,000 | -26.9% | 3.85% | -10.1% |
| BAX | New | BAXTER INTL INC | $111,504,000 | – | 1,725,000 | +100.0% | 3.63% | – |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $108,649,000 | +1944.6% | 725,000 | +1974.4% | 3.54% | +1886.5% |
| HAE | Sell | HAEMONETICS CORP | $84,216,000 | +29.2% | 1,450,000 | -0.2% | 2.74% | +25.5% |
| CVS | New | CVS HEALTH CORP | $81,563,000 | – | 1,125,000 | +100.0% | 2.66% | – |
| ISRG | Buy | INTUITIVE SURGICAL INC | $80,823,000 | +208.6% | 221,470 | +784.5% | 2.63% | +199.7% |
| IQV | New | IQVIA HLDGS INC | $76,693,000 | – | 783,380 | +100.0% | 2.50% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $72,886,000 | +33.6% | 1,309,960 | +8.9% | 2.37% | +29.8% |
| ABBV | Sell | ABBVIE INC | $72,475,000 | -17.3% | 749,410 | -24.0% | 2.36% | -19.7% |
| ANTM | New | ANTHEM INC | $71,144,000 | – | 316,180 | +100.0% | 2.32% | – |
| UNH | Sell | UNITEDHEALTH GROUP INC | $69,445,000 | -7.4% | 315,000 | -17.8% | 2.26% | -10.1% |
| MD | New | MEDNAX INC | $67,421,000 | – | 1,261,620 | +100.0% | 2.19% | – |
| CLVS | Buy | CLOVIS ONCOLOGY INC | $66,221,000 | +24.1% | 973,840 | +50.4% | 2.16% | +20.5% |
| HUM | Buy | HUMANA INC | $65,352,000 | +2.8% | 263,440 | +1.0% | 2.13% | -0.1% |
| LIVN | Sell | LIVANOVA PLC | $49,790,000 | -23.7% | 622,997 | -33.1% | 1.62% | -25.9% |
| ZTS | Buy | ZOETIS INCcl a | $46,473,000 | +82.8% | 645,100 | +61.8% | 1.51% | +77.6% |
| THC | Sell | TENET HEALTHCARE CORP | $44,818,000 | -39.8% | 2,956,351 | -34.8% | 1.46% | -41.5% |
| JNJ | Sell | JOHNSON & JOHNSON | $27,191,000 | -69.4% | 194,610 | -71.5% | 0.88% | -70.3% |
| SYK | New | STRYKER CORP | $25,747,000 | – | 166,280 | +100.0% | 0.84% | – |
| BMY | Buy | BRISTOL MYERS SQUIBB CO | $24,798,000 | +33.6% | 404,670 | +39.0% | 0.81% | +29.7% |
| CVRS | CORINDUS VASCULAR ROBOTICS I | $20,181,000 | -33.6% | 19,981,655 | 0.0% | 0.66% | -35.5% | |
| ABT | New | ABBOTT LABS | $13,979,000 | – | 244,950 | +100.0% | 0.46% | – |
| ZBH | Sell | ZIMMER BIOMET HLDGS INCcall | $12,067,000 | -58.8% | 100,000 | -60.0% | 0.39% | -59.9% |
| DHR | Sell | DANAHER CORP DEL | $11,571,000 | -89.2% | 124,660 | -90.0% | 0.38% | -89.5% |
| BSX | Sell | BOSTON SCIENTIFIC CORP | $9,119,000 | -54.5% | 367,832 | -46.5% | 0.30% | -55.8% |
| MNKKQ | Sell | MALLINCKRODT PUB LTD CO | $6,416,000 | -94.7% | 284,400 | -91.2% | 0.21% | -94.8% |
| FPRX | Sell | FIVE PRIME THERAPEUTICS INC | $2,214,000 | -94.6% | 101,000 | -90.0% | 0.07% | -94.8% |
| PFE | Exit | PFIZER INC | $0 | – | -247,570 | -100.0% | -0.30% | – |
| SRPT | Exit | SAREPTA THERAPEUTICS INCcall | $0 | – | -235,000 | -100.0% | -0.36% | – |
| XLV | Exit | SELECT SECTOR SPDR TRsbi healthcare | $0 | – | -353,960 | -100.0% | -0.97% | – |
| MNKKQ | Exit | MALLINCKRODT PUB LTD COcall | $0 | – | -800,000 | -100.0% | -1.00% | – |
| AGN | Exit | ALLERGAN PLCcall | $0 | – | -150,000 | -100.0% | -1.03% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -338,490 | -100.0% | -1.24% | – |
| HRC | Exit | HILL ROM HLDGS INC | $0 | – | -584,770 | -100.0% | -1.45% | – |
| INCR | Exit | INC RESH HLDGS INCcl a | $0 | – | -930,582 | -100.0% | -1.63% | – |
| VAR | Exit | VARIAN MED SYS INCput | $0 | – | -500,000 | -100.0% | -1.68% | – |
| AET | Exit | AETNA INC NEW | $0 | – | -1,131,674 | -100.0% | -6.03% | – |
| SPY | Exit | SPDR S&P 500 ETF TRput | $0 | – | -1,000,000 | -100.0% | -8.42% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.